| 000 | 01603 a2200421 4500 | ||
|---|---|---|---|
| 005 | 20250513152959.0 | ||
| 264 | 0 | _c19981105 | |
| 008 | 199811s 0 0 eng d | ||
| 022 | _a0022-3565 | ||
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aTonkinson, J L | |
| 245 | 0 | 0 |
_aThe antiproliferative and cell cycle effects of 5,6,7, 8-tetrahydro-N5,N10-carbonylfolic acid, an inhibitor of methylenetetrahydrofolate dehydrogenase, are potentiated by hypoxanthine. _h[electronic resource] |
| 260 |
_bThe Journal of pharmacology and experimental therapeutics _cOct 1998 |
||
| 300 |
_a315-21 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 |
_aAntineoplastic Agents _xpharmacology |
| 650 | 0 | 4 |
_aApoptosis _xdrug effects |
| 650 | 0 | 4 |
_aCell Cycle _xdrug effects |
| 650 | 0 | 4 |
_aCell Division _xdrug effects |
| 650 | 0 | 4 |
_aDeoxyadenine Nucleotides _xmetabolism |
| 650 | 0 | 4 | _aDrug Synergism |
| 650 | 0 | 4 |
_aEnzyme Inhibitors _xpharmacology |
| 650 | 0 | 4 |
_aFolic Acid _xanalogs & derivatives |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aHypoxanthine _xpharmacology |
| 650 | 0 | 4 |
_aMethylenetetrahydrofolate Dehydrogenase (NADP) _xantagonists & inhibitors |
| 650 | 0 | 4 |
_aThymine Nucleotides _xmetabolism |
| 650 | 0 | 4 | _aTumor Cells, Cultured |
| 700 | 1 | _aHabeck, L L | |
| 700 | 1 | _aToth, J E | |
| 700 | 1 | _aMendelsohn, L G | |
| 700 | 1 | _aBewley, J | |
| 700 | 1 | _aShackelford, K A | |
| 700 | 1 | _aGates, S B | |
| 700 | 1 | _aRay, J | |
| 700 | 1 | _aChen, V J | |
| 773 | 0 |
_tThe Journal of pharmacology and experimental therapeutics _gvol. 287 _gno. 1 _gp. 315-21 |
|
| 999 |
_c9730167 _d9730167 |
||